ORIGINAL ARTICLES

Cardiac imaging and non-invasive testing

Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies

C Aggeli, G Giannopoulos, G Roussakis, E Christoforatou, G Marinos, C Toli, C Pitsavos, C Stefanadis

First Cardiology Department, School of Medicine, University of Athens, Hippokration Hospital, Athens, Greece

Dr C Aggeli, 47 Georgiou Papandreou, Zografou, Athens, Greece 15773; caggeli{at}otenet.gr

Objective: The purpose of the present study was to provide evidence regarding the safety of real-time flash-contrast echocardiography combined with dobutamine–atropine stress echo (DASE).

Background: The combination of perfusion assessment using myocardial contrast echocardiography (MCE) with DASE has shown very promising results for the diagnosis of coronary artery disease. Concerns have, however, been expressed regarding the safety of the use of echo-contrast agents in echocardiography.

Design: 5250 individuals (70.8% men, aged 64.6 years (SD 10.6)) were submitted to DASE, with concurrent MCE using a low mechanical index technique with the administration of high-energy impulses in order to assess replenishment time.

Results: No deaths or myocardial infarctions were observed. Sustained ventricular tachycardia (VT) or fibrillation requiring resuscitation occurred in two cases (0.04%). The incidence of other arrhythmic events was: sustained VT not requiring resuscitation, 10 (0.18%); non-sustained VT, 18 (0.34%); atrial tachycardia, 4 (0.08%); atrial fibrillation, 25 (0.48%). Other observed adverse events included: intense headache, 52 (1%); intense back pain, 26 (0.5%). Vagal reactions with marked systolic blood pressure falls were observed in 45 cases (0.9%). Hypersensitivity reactions were reported in 23 cases (0.44%), although no serious cases of hypersensitivity requiring hospitalisation were recorded. The sensitivity, specificity and overall accuracy of DASE/MCE were 92%, 61% and 85%, respectively.

Conclusions: This report of safety data regarding stress-contrast echocardiography in a large series of subjects suggests that this is an exceptionally safe technique, given that in 5250 studies no study-related deaths or myocardial infarctions were encountered, whereas serious adverse events requiring hospitalisation were extremely rare (one in 2625 studies).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

How dangerous is echocardiographic contrast?

Thomas H Marwick
Heart 2008 94: 1522-1523. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Romano, S. (2009). Radiology in Italy: What Is Happening?. Am. J. Roentgenol. 193: W273-W277 [Full Text]  
• Abdelmoneim, S. S., Bernier, M., Scott, C. G., Dhoble, A., Ness, S. A. C., Hagen, M. E., Moir, S., McCully, R. B., Pellikka, P. A., Mulvagh, S. L. (2009). Safety of Contrast Agent Use During Stress Echocardiography: A 4-Year Experience From a Single-Center Cohort Study of 26,774 Patients. J Am Coll Cardiol Img 2: 1048-1056 [Abstract] [Full Text]  
• Main, M. L. (2009). Ultrasound Contrast Agent Safety: From Anecdote to Evidence. J Am Coll Cardiol Img 2: 1057-1059 [Full Text]  
• Gaibazzi, N., Squeri, A., Ardissino, D., Reverberi, C. (2009). Safety of contrast flash-replenishment stress echocardiography in 500 patients with a chest pain episode of undetermined origin within the last 5 days. Eur J Echocardiogr 10: 726-732 [Abstract] [Full Text]  
• Senior, R., Becher, H., Monaghan, M., Agati, L., Zamorano, J., Vanoverschelde, J. L., Nihoyannopoulos, P. (2009). Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 10: 194-212 [Abstract] [Full Text]  
• Marwick, T. H (2008). How dangerous is echocardiographic contrast?. Heart 94: 1522-1523 [Full Text]